Alessandra Ianari

Alessandra Ianari has a strong background in the field of biology and cancer research. Alessandra is currently working as the Director of Disease Biology at Frontier Medicines since May 2022. Prior to this, they held positions at the Broad Institute of MIT and Harvard, where they served as the Associate Director in the Sellers Lab from July 2019 to May 2022 and as a Group Leader/Research Scientist in the William Sellers Lab from March 2018 to June 2019. Before joining the Broad Institute, Alessandra worked as a Senior Research Scientist at C4 Therapeutics - Cancer Biology from March 2016 to February 2018. Alessandra also gained research experience at the Broad Institute - Center for the Development of Therapeutics as a Research Scientist from March 2014 to March 2016. Alessandra's career in the field started at MIT - Koch Institute for Integrative Cancer Research, where they worked as a Postdoctoral Fellow from August 2005 to March 2014. Overall, Alessandra Ianari has extensive experience in cancer research and has held various leadership and research roles in reputable institutions.

Alessandra Ianari has pursued their education at Sapienza Università di Roma MD PhD, although the specific years of their enrollment and graduation are not provided. Additional details regarding their degree name and field of study are also not mentioned.